ReviewCancers2021

Second-Generation Jak2 Inhibitors for Advanced Prostate Cancer: Are We Ready for Clinical Development?

Paul Beinhoff et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.